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In two separate studies, the cholesterol-lowering efficacy of a diet high in monounsaturated fatty
acids (MUFA) was evaluated by means of a randomized crossover trial. In both studies subjects
were randomized to receive either a high-MUFA diet or the control diet first, which they followed
for a period of 8 weeks; following a washout period of 4–6 weeks they were transferred onto the
opposing diet for a further period of 8 weeks. In one study subjects were healthy middle-aged
men (n 30), and in the other they were young men (n 23) with a family history of CHD recruited
from two centres (Guildford and Dublin). The two studies were conducted over the same time
period using identical foods and study designs. Subjects consumed 38 % energy as fat, with 18 %
energy as MUFA and 10 % as saturated fatty acids (MUFA diet), or 13 % energy as MUFA and
16 % as saturated fatty acids (control diet). The polyunsaturated fatty acid content of each diet
was 7 %. The diets were achieved by providing subjects with manufactured foods such as spreads,
‘ready meals’, biscuits, puddings and breads, which, apart from their fatty acid compositions,
were identical for both diets. Subjects were blind to which of the diets they were following on
both arms of the study. Weight changes on the diets were less than 1 kg. In the groups combined
(n 53) mean total and LDL-cholesterol levels were significantly lower at the end of the MUFA
diet than the control diet by 0 × 29 (SD 0 × 61) mmol/l (P , 0× 001) and 0 × 38 (SD 0× 64) mmol/l (P ,
0× 0001) respectively. In middle-aged men these differences were due to a mean reduction in
LDL-cholesterol of ¹11 (SD 12) % on the MUFA diet with no change on the control diet (¹1× 1
(SD 10) %). In young men the differences were due to an increase in LDL-cholesterol
concentration on the control diet of þ6× 2 (SD 13) % and a decrease on the MUFA diet of ¹7× 8
(SD 20) %. Differences in the responses of middle-aged and young men to the two diets did not
appear to be due to differences in their habitual baseline diets which were generally similar, but
appeared to reflect the lower baseline cholesterol concentrations in the younger men. There was a
moderately strong and statistically significant inverse correlation between the change in LDL-
cholesterol concentration on each diet and the baseline fasting LDL-cholesterol concentration
(r ¹ 0× 49; P , 0× 0005). In conclusion, diets in which saturated fat is partially replaced by MUFA
can achieve significant reductions in total and LDL-cholesterol concentrations, even when total
fat and energy intakes are maintained. The dietary approach used to alter fatty acid intakes would
be appropriate for achieving reductions in saturated fat intakes in whole populations.
Coronary heart disease: Monounsaturated fatty acids: Plasma cholesterol
CHD is the major cause of premature death and morbidity
in the UK, with Scotland having the highest rate of CHD
in the world. Recent primary and secondary drug trials
have demonstrated the clear benefit of plasma cholesterol
reduction in both the prevention and treatment of CHD
(Scandinavian Simvastatin Survival Group, 1994; Shepherd
et al. 1995) and re-emphasize the importance of public
health strategies aimed at reducing plasma cholesterol
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levels. Drug treatment has been shown to reduce CHD
mortality by 33 % in subjects with levels of plasma choles-
terol in the upper end of the normal range (Shepherd et al.
1995). These represent individuals who would not normally
be considered candidates for pharmacological interven-
tion and who represent approximately 30 % of the middle-
aged UK population. Effective dietary strategies aimed at
reducing plasma cholesterol concentrations in middle-aged
subjects with moderately raised cholesterol levels, and
at preventing age-associated increases in plasma choleste-
rol in younger age groups, have important public health
implications.
Current dietary recommendations for prevention of CHD
in the UK population focus on the need for reductions in
total fat and especially saturated fatty acids (SFA) (notably
lauric, myristic and palmitic acids), since these have been
shown to raise plasma cholesterol levels in controlled
feeding studies. Expert bodies advise that SFA should
decrease from the current level of intake of 16 % to 10 %
of dietary energy (Department of Health, 1994; Pyo¨ra¨la¨
et al. 1994). Specific recommendations for changes in the
intakes of the other major fatty acid classes, monounsatu-
rated fatty acids (MUFA) and polyunsaturated fatty
acids (PUFA), were not made in the UK Department of
Health (1994) report, because of continuing debate regard-
ing the overall benefits of additional intakes of these fatty
acids.
Since the publication of UK national guidelines for
fat intake in 1991 (Department of Health, 1991), and their
re-iteration in 1994 (Department of Health, 1994), there has
been some movement towards achievement of population
target intakes for total fat and SFA, but levels remain
considerably higher than desired target values (Ministry of
Agriculture, Fisheries and Food, 1992). This may be due,
in part, to lack of consumer preference for low-fat prod-
ucts and low adherence, in the long term, to fat-reduced
commodities.
In recent years we have had the opportunity to investigate
the effects of increasing dietary MUFA intake in two
separate study populations. These were (1) a group of
young men from the UK and Republic of Ireland with a
family history of CHD and (2) a group of normal middle-
aged men from the UK. The groups were studied as part of
two intervention studies which evaluated effects of a high-
MUFA diet on a range of outcome markers including
postprandial lipoproteins, blood coagulation factors and
immune function. Some of the data from these studies
have been reported in detail elsewhere (Roche et al. 1998;
Yaqoob et al. 1998). Details of the diet itself and the
findings for fasting blood lipid variables have not previously
been reported in detail. Since the diets used in the two
studies were identical, and the studies were carried out over
the same time period, we have made a comparison of the
effects of the MUFA diet on fasting blood lipids in young
and middle-aged men who represent subjects with a range of
fasting blood lipid values.
In each study a randomized crossover design was used.
Two diets were compared, one high in SFA, which had a
fatty acid profile similar to current UK fatty acid intakes,
and one high in MUFA, which had a fatty acid profile
similar to current Mediterranean intakes. In the high-MUFA
diet, MUFA were substituted for SFA in an isoenergetic
manner in order to achieve the target intakes of MUFA
(18 % energy) and SFA (10 % energy); total fat intake was
maintained at current levels of intake (38 % energy) and
intakes of other major fatty acids were maintained constant
on the two diets. Although the fatty acid profile of the
MUFA diet used in the present study was close to that of
Mediterranean populations, it was considered important to
provide foods and meals which reflected the food culture of
the UK, which it would be feasible to implement widely in
the UK and Republic of Ireland. A particular feature of the
study was that, in addition to providing subjects with
modified cooking fats and spreads we also provided them
with pre-prepared manufactured recipe meals, biscuits and
puddings which were identical to current commercially
available products, except that they were manufactured
using the experimental oils and spreads. The aim of this
approach was to determine the feasibility of achieving the
dietary fat target intakes using ‘supermarket’ foods com-
monly eaten in the UK and Republic of Ireland.
Methods
Thirty healthy middle-aged men and thirteen healthy
younger men were recruited through general practitioners
in the Guildford area and ten healthy younger men were also
recruited from a second centre in Dublin. The young men
were in good health, but each had a first-degree relative with
CHD (defined as either a myocardial infarct, angioplasty or
coronary artery bypass surgery). All volunteers were in
general good health as assessed by medical history, were
non-smokers, not vegetarian, drank less than 30 units of
alcohol per week (confirmed by the assessment). Subjects’
habitual diets provided 35–45 % energy as fat; no subjects
were taking either a dietary supplement or any medication
known to affect carbohydrate or lipid metabolism. Subjects
abstained from exercise and alcohol consumption for 24 h
before giving a fasted blood sample for screening purposes
and before all subsequent follow-up visits. The biochemical
exclusion limits were one or more of the following: a 12 h
fasting total plasma cholesterol level of . 6 × 5 mmol/l; a
plasma triacylglycerol concentration of . 2 × 5 mmol/l; a
blood glucose level of . 6 × 2 mmol/l or a haemoglobin
level of ,130 g/l.
The study was undertaken after approval from the Uni-
versity of Surrey, the Royal Surrey County Hospital and
Federated Dublin Voluntary Hospitals in Ireland Ethics
Committees; subjects gave their informed written consent
to participate.
Subjects were assigned to receive two diets (control and
MUFA) in a randomized single-blind crossover design of
6 months total duration in a free-living situation. Each diet
period lasted 2 months with a washout period of approxi-
mately 6 weeks between each arm of the study. Following
initial baseline assessments subjects returned to the study
centres at 0, 2, 4, 6 and 8 weeks to collect food and for
further anthropometric and biochemical measurements.
Subjects were provided with foods containing the experi-
mental fats and given advice on meal preparation, eating out
and snacks; foods provided by the investigators accounted
for approximately 60 % of subjects’ total daily fat intake.
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If desired, foods were also provided for subjects’ partners to
aid food preparation in the home and to optimize compliance.
The diet
The aim of the control diet was to achieve fat and fatty
acid intakes equivalent to those of the current UK intake
(Gregory et al. 1990) (% dietary energy: 38 total fat, 16
SFA, 12 MUFA, 6 PUFA); the aim of the MUFA diet was to
replace 40 % of the SFA with MUFA (% dietary energy: 38
total fat, 10 SFA, 18 MUFA, 6 PUFA). Foods were
produced in collaboration with fats and oils producers,
food manufacturers and retailers. Test (MUFA) and control
(SFA) blends of cooking fats and spreads were made by Van
den Bergh Foods, Crawley, Sussex, UK. The MUFA cook-
ing fat was 100 % fat, comprising (g/100 g total fatty acids):
16 : 0, 12; 18 : 0, 6; 18 : 1, 59; 18 : 2, 21; other fatty acids, 2.
The SFA fat comprised (g/100 g total fatty acids): 16 : 0,
28 × 5; 18 : 0, 13; 18 : 1, 34; 18 : 2, 19; other fatty acids, 4× 5.
The spreads were prepared from the same fat blends and
were 80 % fat. The desired fatty acid compositions of the
spreads and fat blends were calculated from details of diet
diaries recorded by fifteen subjects some months before the
intervention study and on the basis of a pilot study con-
ducted 12 months previously. The fatty acid compositions
of the non-intervention foods, which represented non-
exchangeable fats, were estimated. The fatty acid composi-
tions of exchangeable fats and foods prepared from them
(intervention foods), were estimated as the difference
between non-intervention food and total diet target fatty
acid intakes. Vitamins were added at usual levels and salt
added to levels acceptable to the UK palate. These cooking
fats and spreads were used domestically by the subjects and
additionally were provided to Health and Diet Biscuits Ltd,
Sheffield, UK and Sainsburys plc, UK, to replace the usual
extrinsic fat in a range of biscuits (four varieties), recipe
meals (eight varieties), puddings (two varieties) and garlic
bread. Foods that were identical apart from fatty acid
composition were provided for control and MUFA arms
of the study. In addition, commercially available low-fat
recipe meals (ten varieties), potatoes for jacket potato, stir-
fry vegetables and rice were used to offer more food choices
and subjects were able to add the cooking fats and spreads to
these. To achieve the target fatty acid intakes subjects were
required to consume between 30 and 55 g MUFA or SFA
per diet day depending on their habitual fat intake. All
portions of food were designed to contain multiples of 5 g
MUFA or SFA (referred to as a lipid unit). Spreads for
domestic use were provided in standard 250 g packs but
subjects were given a standard serving measure which
represented one lipid unit. The number of lipid units con-
tained within a single portion of a food ranged from 1 to 4
and was labelled on the packaging (examples shown in
Table 1). Thus subjects consumed between 6 and 11 lipid
units per diet day by choosing foods they liked each day to
their lipid unit target. Subjects were asked to eat the recipe
meals provided on 5 d each week and on 2 d they were
allowed to provide their own meals and/or to eat out.
Spreads, cooking fats and biscuits were eaten every day.
Intervention spreads and food accounted for approximately
two-thirds of the total fat intake of the subjects, MUFA or
SFA accounted for approximately 40 % total daily fat intake
on each of the diets. The remaining ‘non-exchangeable’ fat
in the diet came from cheese and dairy products (milk,
cream, ice-cream, yoghurts) whose fatty acid compositions
could not be altered and from the ‘free meal’ periods (two
per week) when subjects were allowed to eat foods other
than those supplied by the investigators. Although subjects
were guided in the amounts of the types of foods which were
allowable, these ‘free meal’ periods were found to be of
importance in allowing subjects a degree of control over
their own meals, and aided compliance.
Dietary assessment
An unstructured diet diary was completed by each subject
for a 5 d period during weeks 3 and 7 of each arm of the
study. Each 5 d diary covered four diet days and one free
day. All fats and foods prepared for the study were analysed
for their nutrient and fatty acid compositions by Reading
Scientific Services Ltd, Reading, Berks., UK. This informa-
tion, along with the portion sizes of the experimental meals,
biscuits, cakes and puddings, was added to the Foodbase
database of UK food tables (Institute of Brain Chemistry,
London, UK). Diet diaries were analysed for nutrient
composition using Foodbase. Amounts of food consumed
were quantified using household measures, standard food
portion sizes and weights of foods provided in manufac-
turer’s information.
Dietary compliance
This was self-assessed using a questionnaire incorporating a
linear-analogue scale. Subjects completed this questionnaire
after 4 and 8 weeks on each arm of the study.
Anthropometric and biochemical measurements
Subjects were weighed once fortnightly by the investigators.
All subjects weighed themselves daily for the first fortnight
on each arm of the study and then once weekly thereafter.
The number of lipid units was adjusted if subjects gained or
lost more than 2 kg over a 2-week period. Blood samples
were collected before (0) and at 2, 4 and 8 weeks within
each arm of the study. Subjects attended the investigation
unit after an overnight fast. On these occasions a 10 ml
blood sample was taken. Plasma was separated immediately
and portions were frozen to ¹208 for later analyses.
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Table 1. Examples of the lipid unit content of intervention foods
Foods Lipid units
Meat lasagne 1
Shepherd’s pie 4
Seafood tagliatelle 3
Vegetable curry 2
Beef cobbler 2
Garlic bread (two slices) 1
Sticky toffee pudding 3
Spread (10 g scoop) 1
Biscuits (4) 1
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Analytical methods
Blood samples were centrifuged at 1700 g immediately
after collection to separate plasma. Enzymic colorimetric
methods were used on a Cobas-Mira analyser (Roche
Products Ltd, Basel, Switzerland) to measure glucose,
cholesterol (Cholesterol PAP Uni-kit; Roche Products
Ltd), triacylglycerol (TAG PAP Uni-kit; Roche Products
Ltd) and non-esterified fatty acids (Wako NEFA-C test kit;
Alpha Laboratories Ltd, Eastleigh, Hants., UK). HDL-
cholesterol levels were determined in fresh plasma
following precipitation of LDL and VLDL (Immuno Ltd,
Sevenoaks, Kent, UK). Following precipitation the super-
natant fraction was removed and stored at ¹208 until analysis.
The interassay CV for these methods was ,5 %. LDL-
cholesterol levels were calculated from Friedewald’s for-
mula (Friedewald et al. 1972) where LDL-cholesterol ¼
total cholesterol ¹ HDL-cholesterol ¹ triacylglycerol/2 × 2,
all values expressed as mmol/l.
In thirteen of the young men plasma triacylglycerol fatty
acid composition was analysed at the end of the control and
MUFA diet periods as previously described (Roche et al.
1998). In twenty-two middle-aged men plasma phospholipid
fatty acid composition was analysed at the end of the control
and MUFA diet periods as previously described (Yaqoob
et al. 1998). These data were used to provide an objective
index of dietary compliance.
Data handling and statistics
Results are expressed as means with their standard errors in
figures and means and standard deviations in tables. Statis-
tical analysis was performed using Data Desk 4.1 (Data
Descriptions Inc., Ithaca, NY, USA). Data were analysed
by diet and age group and by time. Normal distribution of the
data was achieved by transformation as appropriate. P , 0× 05
was accepted as the level of statistical significance.
Results
Young Irish men were significantly younger than young UK
men (Table 2; P , 0 × 001), and as expected, the young men
as a whole were significantly younger than the middle-aged
men (P , 0 × 0001). Middle-aged men had a higher BMI than
young men (P , 0 × 03). Young Irish men had lower fasting
total and LDL-cholesterol levels (P , 0 × 01) than young UK
men and measurements of plasma total cholesterol and
triacylglycerol levels were higher in the middle-aged men
than the young men (all) (P , 0 × 003 and P , 0 × 02 respec-
tively) (Table 2). Habitual diets did not differ between either
young Irish and young UK men, or between young men (all)
and middle-aged men. Although there was a trend for
intakes of dietary SFA to be lower in young Irish men
than both UK groups this difference did not reach a level of
statistical significance.
The dietary intervention successfully achieved the target
fatty acid intakes, with mean levels of intake for the group
as a whole (n 53) of (% energy): 15 × 9 (SD 1 × 5) SFA and 12 × 9
(SD 1 × 5) MUFA on the control diet and 10 × 1 (SD 1 × 7) SFA
and 17 × 7 (SD 1 × 9) MUFA on the MUFA diet (combined data
not shown in tables). For both young and middle-aged men
the only differences between control and MUFA diets were
the intakes of SFA and MUFA which were significantly
different between the two diets for both age groups (Table 3;
P , 0 × 0001 in all cases). Percentages of energy as total fat,
PUFA, carbohydrate and protein did not differ between the
two diets. Comparison of nutrient intakes in young and
middle-aged men (Table 3) showed that there were more
differences between the two age groups for the MUFA diet
than for the control diet. On the MUFA diet young men
consumed significantly less energy as protein (P , 0 × 01)
and carbohydrate (P , 0 × 05) and more energy as total fat
(P , 0 × 0001), SFA (P , 0 × 0001), MUFA (P , 0 × 01) and
PUFA (P , 0 × 004) than did middle-aged men on the same
diet. During the control diet period young men obtained
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Table 2. Anthropometric, blood lipid and dietary fat characteristics of young (UK and Irish) and middle-aged (UK only) subjects at baseline
(Mean values and standard deviations)
Middle-aged Statistical significance
Young men men of between-group
differences (unpaired t test): P ¼
Irish (n 10) UK (n 13) All (n 23) All (n 30)
Young Irish Young all
Mean SD Mean SD Mean SD Mean SD v. young UK v. middle-aged all
Age (years) 23× 8 3× 6 33× 0 5× 1 28× 7 6× 6 49× 1 5× 4 0× 001 0× 0001
BMI (kg/m2) 25× 1 3× 1 24× 3 2× 6 24× 5 2× 9 26× 2 2× 6 NS 0× 03
Plasma variables (mmol/l)
Total-C 4× 1 0× 9 5× 2 1× 0 4× 6 1× 1 5× 5 1× 0 0× 01 0× 003
LDL-C 2× 8 0× 8 3× 8 0× 9 3× 3 1× 2 3× 9 0× 9 0× 01 0× 07
HDL-C 1× 2 0× 3 1× 1 0× 2 1× 1 0× 3 1× 2 0× 2 NS NS
TAG 1× 1 0× 4 1× 2 0× 4 1× 2 0× 4 1× 6 0× 7 NS 0× 02
Glucose 5× 5 0× 7 5× 5 0× 8 5× 5 0× 7 5× 5 0× 5 NS NS
Dietary variables (% energy)
Total fat 38× 0 4× 3 39× 8 7× 0 39× 1 5× 5 38× 7 6× 2 NS NS
SFA 12× 9 2× 9 15× 7 7× 0 14× 1 4× 0 14× 5 4× 2 NS NS
MUFA 12× 7 3× 5 13× 7 6× 0 13× 1 4× 7 12× 2 3× 0 NS NS
PUFA 6× 5 1× 6 6× 2 2× 0 6× 3 1× 8 6× 8 3× 3 NS NS
Total-C, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol; TAG, triacylglycerol; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids;
PUFA, polyunsaturated fatty acids.
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significantly more energy from protein than did middle-
aged men (P , 0 × 0001), but other differences did not reach
levels of statistical significance.
Some assessment of the degree of compliance with the
diet was provided by measurement of fasting plasma tri-
acylglycerol fatty acid composition in a cohort of the young
men and by plasma phospholipid fatty acid composition in a
cohort of the middle-aged men (Table 4). In young men
there was a significantly higher plasma triacylglycerol
MUFA content at the end of the MUFA diet compared
with the end of the control diet (P , 0 × 002). There was a
trend for plasma triacylglycerol SFA content to be reduced
on the MUFA diet, but this did not reach a level of statistical
significance (P , 0 × 07). Similarly in middle-aged men,
plasma phospholipid MUFA content was higher at the end
of the MUFA diet than the control diet (P , 0 × 0001) and
there was an opposite trend in the SFA content but the latter
did not reach a level of statistical significance. PUFA
content did not show any change in any of the plasma
lipids for either of the age groups on either of the two diets.
Table 5 shows the mean values for fasting blood lipids for
the group as a whole at weeks 0, 2, 4 and 8 of the control and
MUFA diets. Total and LDL-cholesterol levels were sig-
nificantly lower at the end of the MUFA diet than the control
diet (P , 0 × 0001 and P , 0 × 001 respectively). During the
control diet there were no significant changes from baseline
to week 8 in any of the fasting lipid values. During the
MUFA diet there were significant reductions in fasting total
and LDL-cholesterol levels between baseline and week 8
(P , 0 × 005 and P , 0 × 001 respectively). There were no
significant differences in HDL-cholesterol, triacylglycerol
or glucose concentrations between the two diets in either
group. There were no significant differences in body weight
at the end of the control and MUFA diets. However, during
each 8-week diet period there was a small increase in body
weight of approximately 1 kg on both control and MUFA
diets (P , 0 × 05 both diets).
The mean difference for the end of the control diet
compared with the end of the MUFA diet for total choles-
terol was 0 × 29 (SD 0 × 61) mmol/l (P , 0 × 001) and for LDL-
cholesterol was 0 × 38 (SD 0 × 64) mmol/l (P , 0 × 0001).
Differences were found in the nature of the responses of
young men and middle-aged men to the control and MUFA
diets (Fig. 1). Middle-aged men showed a mean reduction of
¹11 (SD 12) % in LDL-cholesterol from baseline on the
MUFA diet, with no change in response to the control diet
(¹1 × 1 (SD 10) %). In contrast young men showed an
increase in LDL-cholesterol on the control diet of þ6 × 2
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Table 3. Mean daily intakes of energy and percentages of energy as protein, carbohydrate and fat and the major fatty acid classes for young and
middle-aged subjects on control and monounsaturated fatty acid (MUFA)-enriched diets*
(Mean values and standard deviations)
Young men (n 23) Middle-aged men (n 30) Statistical significance of differences between groups: P ¼
Control MUFA Control MUFA Control v. Control v. Young v. Young v.
MUFA MUFA middle-aged middle-aged
Mean SD Mean SD Mean SD Mean SD young middle-aged control MUFA
Energy (MJ) 11× 1 1× 8 11× 6 1× 9 11× 0 1× 9 10× 2 1× 5 NS NS NS NS
% Energy as:
Protein 12× 4 1× 7 11× 9 1× 3 15× 2 0× 2 13× 5 0× 8 NS NS 0× 0001 0× 01
Carbohydrate 42× 9 3× 8 43× 7 4× 2 43× 8 6× 3 45× 2 0× 9 NS NS NS 0× 05
Fat 41× 2 3× 9 40× 6 3× 6 39× 4 6× 8 37× 4 0× 4 NS NS NS 0× 0001
SFA 17× 1 1× 7 12× 0 2× 3 16× 2 3× 7 9× 6 1× 2 0× 0001 0× 0001 NS 0× 0001
MUFA 13× 8 1× 7 18× 3 1× 7 13× 2 2× 1 17× 2 1× 3 0× 0001 0× 0001 NS 0× 01
PUFA 7× 0 1× 0 7× 2 1× 0 7× 0 1× 0 6× 6 0× 4 NS NS NS 0× 004
SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids.
* For details of subjects and diets, see Table 2 and pp. 440–442.
Table 4. Values for fasting plasma phospholipid fatty acid composition (middle-aged men) and plasma triacylglycerol fatty acid composition (young
men) at the end of control and monounsaturated fatty acid (MUFA)-enriched diets*
(Mean values and standard deviations)
Young men Middle-aged men
Plasma triacylglycerol fatty acids Plasma phospholipid fatty acids
(n 13) (n 22)
Statistical significance Statistical significance
Control MUFA of differences: P ¼ Control MUFA of differences: P ¼
Mean SD Mean SD Control v. MUFA Mean SD Mean SD Control v. MUFA
g/100 g total fatty acids
SFA 41× 5 10× 0 35× 1 12× 9 0× 07 52× 8 6× 4 49× 9 4× 5 0× 09
MUFA 36× 6 7× 2 45× 6 6× 8 0× 002 13× 0 1× 9 15× 5 1× 8 0× 0001
PUFA 17× 2 6× 1 17× 2 3× 5 NS 30× 3 5× 1 30× 1 4× 1 NS
SFA, saturated fatty acids; PUFA, polyunsaturated fatty acids.
* For details of subjects and diets, see Table 2 and pp. 440–442.
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(SD 13) % and a decrease in LDL-cholesterol of ¹7 × 8 (SD
20) % on the MUFA diet. The different responses of the two
age groups to the two diets appears to be a reflection of their
different baseline fasting LDL-cholesterol values since, as
shown in Fig. 2, there was an inverse and significant
444 C. M. Williams et al.
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Fig. 1. Percentage changes in plasma LDL-cholesterol concentration
in all subjects (n 53) and in middle-aged (n 30) and young (n 23) men
from baseline to the end of an 8-week period of consuming a control
diet (A) or a monounsaturated fatty acid-enriched diet (A).
Fig. 2. Correlation between percentage change in plasma LDL-
cholesterol concentration and baseline LDL-cholesterol concentra-
tion (mmol/l) in fifty-three male subjects consuming a control diet (W)
or a monounsaturated fatty acid-enriched diet (X).
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correlation between baseline LDL-cholesterol levels and the
percentage change in LDL-cholesterol from baseline to
week 8 on each diet (r ¹0 × 49; P , 0 × 0005). The data
indicate that subjects with the highest starting cholesterol
concentrations showed the most marked reductions on the
MUFA diet, whilst subjects with the lowest cholesterol
concentrations showed the most marked increases on the
control diet.
Discussion
As anticipated, the MUFA diet, which achieved a marked
reduction in SFA intake to a mean level of 10 × 1 (SD 1 × 7) %
energy, achieved a significant reduction in LDL-cholesterol
of 0 × 38 mmol/l in fifty-three healthy normocholesterolaemic
young and middle-aged men. An important and novel aspect
of the study was the use of typical manufactured foods as the
intervention vehicles. Compliance with the diet was found
to be excellent and the food products were of similar quality
and palatability for both the control and MUFA arms of the
study. The study used foods which were of similar quality
and type to those available in UK and Irish supermarkets;
this increased the acceptability of the diet and made it
feasible to carry out a study which, although it used
free-living subjects, was well controlled in terms of its
single-blind design and achievement of the target fatty
acid intakes, and highly acceptable with respect to the
volunteers’ lifestyles.
The mean difference in the levels of total cholesterol at
the end of the control and the MUFA diets (0 × 29 (SD 0 × 61)
mmol/l) was less than that which would be predicted by the
Keys et al. (1957) equation (0 × 39 mmol/l), which uses the
changes in dietary intake of SFA, PUFA and cholesterol to
estimate the change in blood cholesterol. However the
difference in LDL-cholesterol values between the two
diets (0 × 38 (SD 0 × 64) mmol/l) was very close to that
predicted by the Keys et al. (1957) equation. More recently
Yu et al. (1995) have produced alternative equations which
take into account the now well-accepted neutral effects of
stearic acid on blood cholesterol levels. When this equation
was applied to the diets used in the present study and the
values for stearic acid intakes on the control and MUFA
diets were used in the equation, the predicted changes in
total cholesterol and LDL-cholesterol were found to be 0 × 21
and 0 × 11 mmol/l respectively, considerably less than the
differences actually found. It is difficult from these compari-
sons to determine whether the addition of MUFA in the
present diet added to the cholesterol-lowering effects of the
reduced SFA intake. Comparison with the Keys et al. (1957)
equation would suggest that the reduction in cholesterol
reported here was entirely due to displacement of SFA from
the diet, with no additional hypocholesterolaemic effect
attributable to addition of MUFA, whereas comparison
with the Yu et al. (1995) equation would suggest that the
diet produced a reduction in cholesterol additional to that
predicted from the changes in intakes of the cholesterol-
raising SFA.
Although the data presented here demonstrate a signifi-
cant effect of a MUFA-rich diet on total and LDL-choles-
terol concentrations, there was considerable individual
variability in subjects’ responses to the diet. Analysis of
the data for middle-aged and young men separately showed
the two groups to differ in their response to the two diets.
In the middle-aged men there was a clear effect of the
MUFA diet itself, with a mean reduction in LDL-cholesterol
concentration of ¹11 %, with no change in response to the
control diet. In the young men, there was a mean increase in
LDL-cholesterol concentration of þ6 × 2 % on the control
diet. In contrast there was a smaller reduction (¹7 × 8 %) in
LDL-cholesterol on the MUFA diet. Nevertheless the net
effect of the two diets was similar in the two groups, with
comparison of differences between end of the control
diet and end of the MUFA diet producing similar findings,
which was a net difference in cholesterol levels of 11–14 %
between the two diets. A possible explanation for the dif-
ferent responses of the two groups of men to the control and
MUFA diets was that the habitual diets of the two groups
might have differed before the interventions, so that the
responses to the control and MUFA diets varied according
to baseline habitual diets. This was considered to be a
plausible explanation since the young men each had a
close family history of CHD and may have been more
responsive to previous dietary advice concerning choles-
terol reduction, thereby influencing their habitual fatty acid
intakes. However, habitual dietary intakes assessed in the
study by means of a 4 d diet diary, showed no significant
differences in total fat or of the major fatty acid classes
between the young and middle-aged men. It was noted,
however, that young Irish men had lower intakes of SFA
than either young or middle-aged UK men but the differ-
ences were not statistically significant. Caution must be
applied in excluding differences in habitual diet as a
possible explanation for these findings since there are
major limitations in estimates of fatty acid intakes in free
living populations due to the inadequate and outdated data
available for fatty acid compositions in most food com-
position databases. Values for the complete fatty acid
compositions of individual foods are limited to only a
small proportion of the foods entered into the database
and because of frequent changes in manufacturers’ specifi-
cations, are known to be outdated even for major fat sources
such as margarines and oils. Much greater confidence can be
placed on the estimates of fatty acid intakes on the control
and MUFA diets since the majority of foods used in the study,
which represented 60 % of total fat intake, were directly
analysed for their fat contents and fatty acid compositions and
this information was added to the database allowing more
accurate estimation of true fat and fatty acid intakes. Non-
intervention fat-containing foods included cheese and other
dairy products, whose compositions are subject to less
variability than other foods. Greater reliability could also
be placed on portion sizes during the intervention study since
pre-packaged foods were of standard size.
Another explanation for the different responses of young
and middle-aged men may be that on the MUFA diet, the
young men were achieving a greater proportion of their
energy from fat and had a higher energy intake from SFA
than did the middle-aged men. This may have mitigated
against some of the benefits of the MUFA diet in this group.
However the data shown in Fig. 2 suggest that the most
likely explanation for the findings is that the effects of
both diets are determined in part by the starting values for
445Cholesterol reduction with MUFA
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LDL-cholesterol, which are strongly associated with age.
These data suggest that where baseline LDL-cholesterol
level is elevated subjects are more likely to respond to a
low-SFA–high-MUFA diet with a reduction in cholesterol
levels, whereas the opposite is the case for subjects with
modest or low cholesterol values. The data in Fig. 2 also
illustrate the great heterogeneity in response to the two
diets. Whilst variations in compliance may have contributed
to this, other factors including genetic influences, need to be
considered.
The public health considerations of the findings of the
present study are worthy of some discussion. Law et al.
(1994) have estimated that a 0 × 6 mmol/l reduction in LDL-
cholesterol level in middle-aged men would produce a cor-
responding decrease in the risk of CHD of 25–30 %. Based
on these data the dietary changes achieved in the present
study, if extrapolated to the middle-aged male population of
the UK, would be expected to reduce risk of CHD by 16 %,
with considerable benefit in terms of quality of life and
cost to the health service. The 1994 report Nutritional
Aspects of Cardiovascular Disease (Department of Health,
1994) concluded that reductions in plasma total and LDL-
cholesterol could best be achieved by a reduction in dietary
SFA from the current level of intake of 16 % energy to the
desired level of 10 % energy. The diet investigated in the
present study achieved the same outcome, but without need
for a reduction in the overall level of fat intake. The data
presented here suggest that a high-MUFA diet offers a
practical means of achieving target SFA intakes and of
reducing plasma total and LDL-cholesterol concentrations,
and may be more acceptable to some consumers than advice
to reduce fat intakes to levels less than 33 % of dietary
energy. The method used to achieve target dietary intakes in
the present study is one which would be readily achievable
if sufficient products were available in food retail outlets.
No technological or other problems were encountered in
producing the MUFA-enriched versions of the commer-
cially available products, although some modifications
might be needed to achieve a more comprehensive range
of items.
The present diet may be of particular value in children
and adolescents in whom fat and energy restriction may be
unnecessary, but in whom attempts to achieve and sustain
low circulating cholesterol levels could have major benefits
in later life. In overweight and obese adults, low-fat diets
must continue to be advised, since energy restriction
remains the focus of attention in these groups.
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